ストックスクリーナーアプリを入手
54.63
3.62%
-2.05
前日終値:
$56.68
開ける：
$56.82
24時間の取引高:
653.49K
Relative Volume:
0.70
時価総額：
$5.94B
収益：
$628.56M
当期純損益:
$141.82M
株価収益率:
43.36
EPS:
1.26
ネットキャッシュフロー:
$142.60M
1週間 パフォーマンス:
-6.87%
1か月 パフォーマンス:
-8.72%
6か月 パフォーマンス:
+24.36%
1年 パフォーマンス:
+116.87%
1日の値動き範囲:
$53.79
$57.51
1週間の範囲:
$53.79
$61.09
52週間の値動き範囲:
$20.84
$75.00
Corcept Therapeutics Inc Stock (CORT) Company Profile
名前
Corcept Therapeutics Inc
セクター
電話
650.688.8803
住所
101 REDWOOD SHORES PARKWAY, REDWOOD CITY
CORT を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CORT
Corcept Therapeutics Inc
|
54.63 | 5.94B | 628.56M | 141.82M | 142.60M | 1.26 |
|
VRTX
Vertex Pharmaceuticals Inc
|
492.69 | 131.41B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
637.36 | 72.26B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
589.15 | 35.93B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
268.46 | 34.75B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
267.39 | 28.24B | 3.81B | -644.79M | -669.77M | -6.24 |
Corcept Therapeutics Inc Stock (CORT) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2023-11-06 | アップグレード | Truist | Hold → Buy |
| 2023-04-11 | 開始されました | SVB Securities | Market Perform |
| 2023-04-04 | 開始されました | Piper Sandler | Overweight |
| 2023-02-15 | ダウングレード | Jefferies | Buy → Hold |
| 2022-08-01 | ダウングレード | Truist | Buy → Hold |
| 2022-07-27 | アップグレード | Jefferies | Hold → Buy |
| 2022-06-27 | 再開されました | Canaccord Genuity | Buy |
| 2022-02-02 | 開始されました | Canaccord Genuity | Buy |
| 2022-01-28 | 開始されました | Truist | Buy |
| 2020-08-05 | ダウングレード | Jefferies | Buy → Hold |
| 2019-09-24 | 開始されました | Jefferies | Buy |
| 2019-09-06 | 開始されました | H.C. Wainwright | Buy |
| 2019-02-04 | ダウングレード | B. Riley FBR | Buy → Neutral |
| 2018-08-10 | 繰り返されました | Stifel | Hold |
| 2018-05-31 | ダウングレード | Stifel | Buy → Hold |
| 2018-03-09 | 開始されました | B. Riley FBR, Inc. | Buy |
| 2017-08-31 | 開始されました | Stifel | Buy |
| 2017-02-02 | 開始されました | Ladenburg Thalmann | Buy |
| 2015-04-21 | 開始されました | FBR Capital | Outperform |
| 2014-01-13 | ダウングレード | Stifel | Buy → Hold |
| 2013-08-09 | ダウングレード | Janney | Buy → Neutral |
| 2013-08-09 | ダウングレード | Ladenburg Thalmann | Buy → Neutral |
| 2012-02-21 | 繰り返されました | JMP Securities | Mkt Outperform |
| 2010-01-06 | アップグレード | Ladenburg Thalmann | Neutral → Buy |
| 2008-07-17 | 開始されました | Rodman & Renshaw | Mkt Outperform |
| 2007-06-21 | アップグレード | Punk, Ziegel & Co | Mkt Perform → Accumulate |
すべてを表示
Corcept Therapeutics Inc (CORT) 最新ニュース
Did Corcept Therapeutics Incorporated Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky InvestigateCORT - ACCESS Newswire
Why Is Corcept (CORT) Down 5.3% Since Last Earnings Report? - Yahoo Finance
Corcept Therapeutics president Sean Maduck sells $102,804 in stock By Investing.com - Investing.com South Africa
Corcept therapeutics officer sells shares worth $25,504 - Investing.com India
Corcept therapeutics CEO Joseph Belanoff sells $120k in stock - Investing.com India
Corcept Therapeutics president Sean Maduck sells $102,804 in stock - Investing.com
3 Reasons to Sell CORT and 1 Stock to Buy Instead - Yahoo Canada Finance
Avantax Advisory Services Inc. Invests $293,000 in Corcept Therapeutics Incorporated (NASDAQ:CORT) - Defense World
Global Cushing's Syndrome Treatment Market: Research & - openPR
Corcept Therapeutics Incorporated (NASDAQ:CORT) Stake Raised by Natixis Advisors LLC - Defense World
Cushing's Syndrome Pipeline 2025: Therapies, MOA Insights, - openPR
Research Analysts Offer Predictions for CORT Q1 Earnings - Defense World
Is Corcept Therapeutics (CORT) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Raymond James Financial Inc. Makes New $12.08 Million Investment in Corcept Therapeutics Incorporated (NASDAQ:CORT) - Defense World
Proficio Capital Partners LLC Takes $1.60 Million Position in Corcept Therapeutics Incorporated (NASDAQ:CORT) - Defense World
Shareholders that lost money on Corcept Therapeutics Incorporated(CORT) should contact Levi & Korsinsky about Securities Fraud InvestigationCORT - ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corcept Therapeutics IncorporatedCORT - PR Newswire
Victory Capital Management Inc. Increases Stock Holdings in Corcept Therapeutics Incorporated (NASDAQ:CORT) - Defense World
Charles Schwab Investment Management Inc. Acquires 25,073 Shares of Corcept Therapeutics Incorporated (NASDAQ:CORT) - Defense World
Corcept therapeutics director sells $117,920 in stock - Investing.com India
Corcept therapeutics director sells $117,920 in stock By Investing.com - Investing.com South Africa
Corcept trial to evaluate Cushing’s and hypertension - Cushing's Disease News
Head-To-Head Review: Corcept Therapeutics (NASDAQ:CORT) vs. Ocular Therapeutix (NASDAQ:OCUL) - Defense World
NVO Stock Down 9% as CagriSema Misses Target in Second Obesity Study - TradingView
Bronstein, Gewirtz & Grossman, LLC Encourages Corcept Therapeutics Incorporated (CORT) Shareholders to Inquire about Securities Investigation - Markets Insider
Before You Invest, Make Sure You Check This Corcept Therapeutics Inc (NASDAQ: CORT) Analysis - Stocks Register
Corcept Therapeutics Stock Surges Amid Clinical Trial News - TipRanks
Bronstein, Gewirtz & Grossman, LLC Is Investigating Corcept Therapeutics Incorporated (CORT) And Encourages Shareholders to Connect - Markets Insider
Corcept Therapeutics launches study on link between high cortisol and resistant hypertension - Marketscreener.com
Corcept Therapeutics initiates Momentum trial to treat resistant hypertension - TipRanks
Corcept Therapeutics Initiates MOMENTUM Trial to Determine Prevalence of Hypercortisolism in Patients with Resistant Hypertension - Business Wire
Bank of New York Mellon Corp Has $29.72 Million Holdings in Corcept Therapeutics Incorporated (NASDAQ:CORT) - Defense World
Corcept Begins 1,000-Patient Clinical Trial for Resistant Hypertension - StockTitan
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Corcept Therapeutics Incorporated (CORT) And Encourages Shareholders to Reach Out - Markets Insider
Corcept's NDA for its hypercortisolism treatment gets FDA nod - MSN
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Corcept Therapeutics Incorporated (CORT) and Encourages Shareholders to Learn More About the Investigation - Markets Insider
Corcept Shares Rise More Than 55% in 6 Months: Here's Why - Nasdaq
Are Options Traders Betting on a Big Move in Corcept Therapeutics (CORT) Stock? - Nasdaq
Corcept Therapeutics Incorporated (CORT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - Markets Insider
CORT's Q4 Earnings and Revenues Fall Short of Estimates - MSN
Corcept Therapeutics president sells over $1.1 million in stock By Investing.com - Investing.com South Africa
FDA decision on relacorilant for Cushing’s expected by year’s end - Cushing's Disease News
Bronstein, Gewirtz & Grossman, LLC Is Investigating Corcept Therapeutics Incorporated (CORT) And Encourages Investors to Connect - Markets Insider
Corcept Therapeutics' (NASDAQ:CORT) Earnings Offer More Than Meets The Eye - Yahoo Finance
Q4 Earnings Outperformers: Corcept (NASDAQ:CORT) And The Rest Of The Branded Pharmaceuticals Stocks - The Globe and Mail
Corcept Therapeutics president sells over $1.1 million in stock - Investing.com
Corcept Therapeutics CEO Joseph Belanoff sells $178,097 in stock By Investing.com - Investing.com South Africa
Corcept Therapeutics executive sells $1.18 million in stock - Investing.com
Corcept Therapeutics CEO Joseph Belanoff sells $178,097 in stock - Investing.com India
Corcept Therapeutics executive sells $1.18 million in stock By Investing.com - Investing.com UK
Corcept: Turning A Corner, But Risks Remain (NASDAQ:CORT) - Seeking Alpha
Corcept Therapeutics Inc (CORT) 財務データ
収益
当期純利益
現金流量
EPS
Corcept Therapeutics Inc (CORT) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Lyon Joseph Douglas | See Remarks |
Mar 24 '25 |
Sale |
60.58 |
421 |
25,504 |
9,009 |
| BELANOFF JOSEPH K | Chief Executive Officer |
Mar 24 '25 |
Sale |
60.83 |
1,974 |
120,084 |
3,017,437 |
| Maduck Sean | See Remarks |
Mar 24 '25 |
Option Exercise |
5.05 |
1,697 |
8,570 |
87,319 |
| Maduck Sean | See Remarks |
Mar 24 '25 |
Sale |
60.58 |
1,697 |
102,804 |
85,622 |
| Swisher Daniel N JR | Director |
Mar 10 '25 |
Option Exercise |
12.13 |
2,200 |
26,686 |
2,200 |
| Swisher Daniel N JR | Director |
Mar 10 '25 |
Sale |
53.60 |
2,200 |
117,920 |
0 |
0.39%
0.34%
大文字化:
|
ボリューム (24 時間):